Skip to main content
. 2024 Aug 12;13(3):493–528. doi: 10.1007/s40119-024-00377-2

Table 5.

Recommendations for surgical ablation

COR LOE Recommendations
graphic file with name 40119_2024_377_Figa_HTML.gif graphic file with name 40119_2024_377_Figb_HTML.gif 1. For patients with AF who are undergoing cardiac surgery, concomitant surgical ablation is beneficial to reduce the risk of recurrent AF
graphic file with name 40119_2024_377_Figc_HTML.gif graphic file with name 40119_2024_377_Figd_HTML.gif 2. In patients undergoing surgical ablation, anticoagulation is reasonable for at least 3 months after the procedure to reduce thromboembolic risk
graphic file with name 40119_2024_377_Fige_HTML.gif graphic file with name 40119_2024_377_Figf_HTML.gif 3. For patients with symptomatic persistent AF refractory to antiarrhythmic drug therapy, hybrid epicardial and endocardial ablation might be reasonable to reduce the risk of recurrent atrial tachyarrhythmia

COR Class (Strength) of recommendation

LOE Level (Quality) of evidence

B-R Moderate-quality evidence from 1 or more randomized controlled trials (RCTs); Meta-analyses of moderate-quality RCTs

B-NR Data derived from nonrandomized trials

AF atrial fibrillation

Adapted from reference 3, with permission